9亿，齐济投资二期人民币基金完成首关

Core Insights - Qiji Investment has successfully completed the first closing of its second RMB fund, raising 900 million RMB, which lays a foundation for future investments in the healthcare sector [1] - The firm aims to focus on global cutting-edge technology-driven healthcare and life sciences, targeting globally competitive innovative results for investment [1] - Qiji Investment emphasizes high-quality investment opportunities in biopharmaceuticals, medical devices, and in vitro diagnostics, addressing unmet patient needs and creating collaborative value [1] Summary by Sections - Fundraising Achievement - Qiji Investment's second RMB fund has raised 900 million RMB in its first closing, marking a significant milestone for the firm [1] - Investment Strategy - The company continues to build a "sharpshooter" level investment team and a precise investment system as part of its strategic focus [1] - The second fund will maintain a deep focus on innovative healthcare technologies and life sciences, aiming to lead industry value creation through differentiated strategies [1] - Sector Focus - Qiji Investment is particularly interested in biopharmaceuticals, medical devices, and in vitro diagnostics, concentrating on segments with significant advantages and unmet patient needs [1] - The firm is committed to empowering portfolio companies and advancing medical innovation to create societal value [1]